OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Races of small molecule clinical trials for the treatment of COVID‐19: An up‐to‐date comprehensive review
Suwen Hu, Songwei Jiang, Qi Xiang, et al.
Drug Development Research (2021) Vol. 83, Iss. 1, pp. 16-54
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Paxlovid: Mechanism of Action, Synthesis, and In Silico Study
Mahrokh Marzi, Mohammad Kazem Vakil, Maryam Bahmanyar, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 103

Potential Therapeutics and Vaccines: Current progress and challenges in developing antiviral treatments or vaccines for Oropouche Virus
Abhishek Vijukumar, Ashok Kumar, Hardik Kumar
Diagnostic Microbiology and Infectious Disease (2025) Vol. 111, Iss. 3, pp. 116699-116699
Closed Access

An effective COVID-19 classification in X-ray images using a new deep learning framework
P. Thilagavathi, R. Geetha, S. Jothi Shri, et al.
Journal of X-Ray Science and Technology (2025)
Open Access

Identification of potent TMPRSS4 inhibitors through structural modeling and molecular dynamics simulations
Ismail Hdoufane, Mehdi Oubahmane, Youssef Habibi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

On QSPR analysis of pulmonary cancer drugs using python-driven topological modeling
Huiling Qin, Mazhar Hussain, Muhammad Farhan Hanif, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Decoration of copper nanoparticles (Cu2O NPs) over chitosan-guar gum: Its application in the Sonogashira cross-coupling reactions and treatment of human lung adenocarcinoma
Xu Cheng, Saba Hemmati, Mozhgan Pirhayati, et al.
International Journal of Biological Macromolecules (2025) Vol. 305, pp. 141122-141122
Closed Access

Harnessing the FOXO-SIRT1 axis: insights into cellular stress, metabolism, and aging
Saurabh Gupta, Muhammad Afzal, Neetu Agrawal, et al.
Biogerontology (2025) Vol. 26, Iss. 2
Closed Access

Hypoxia-inducible factor and cellular senescence in pulmonary aging and disease
Riya Thapa, Arockia Babu Marianesan, Arcot Rekha, et al.
Biogerontology (2025) Vol. 26, Iss. 2
Open Access

miR-210: A non-invasive biomarker for hypoxia-driven lung cancer diagnosis and therapy
Ahsas Goyal, Muhammad Afzal, Kavita Goyal, et al.
Clinica Chimica Acta (2025), pp. 120215-120215
Closed Access

Design, synthesis and evaluation of diphenyl ether-based kaiso inhibitors with enhanced potency
Taofeng Lin, Zhongqi Li, Juanchan Yuan, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130158-130158
Closed Access

Impact of β-Carotene on the Structural and Thermal Behavior of β-Lactoglobulin: A Study Integrating Spectroscopy, Docking, and MD
Bahareh Yousefi, Saad Ali Alshehri, Sadegh Farhadian, et al.
Journal of Molecular Structure (2025), pp. 141965-141965
Closed Access

Deciphering Host–Virus Interactions and Advancing Therapeutics for Chronic Viral Infection
Majid Eslami, Neda Arjmand, Fatemeh Mahmoudian, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 390-390
Open Access

Application of Machine Learning (ML) approach in discovery of novel drug targets against Leishmania: A computational based approach
Hayat Ali Shah, Sabina Yasmin, Md. Yousuf Ansari
Computational Biology and Chemistry (2025), pp. 108423-108423
Closed Access

Repurposing FDA approved drugs as possible anti-SARS-CoV-2 medications using ligand-based computational approaches: sum of ranking difference-based model selection
Priyanka De, Vinay Kumar, Supratik Kar, et al.
Structural Chemistry (2022) Vol. 33, Iss. 5, pp. 1741-1753
Open Access | Times Cited: 19

Are we ready to combat the ecotoxicity of COVID-19 pharmaceuticals? An in silico aquatic risk assessment
Kabiruddin Khan, Supratik Kar, Kunal Roy
Aquatic Toxicology (2023) Vol. 256, pp. 106416-106416
Open Access | Times Cited: 10

Novel scaffolds identification against Mpro of SARS-CoV-2 using shape based screening and molecular simulation methods
Pawan Gupta, Umesh Panwar, Sanjeev Kumar Singh
Chemical Physics Impact (2024) Vol. 8, pp. 100496-100496
Open Access | Times Cited: 3

Clinical outcomes of COVID-19 infection in patients with osteoporosis: a nationwide cohort study in Korea using the common data model
Seong Hee Ahn, Sung‐Hyo Seo, Chai Young Jung, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3

Nonpeptidic Irreversible Inhibitors of SARS-CoV-2 Main Protease with Potent Antiviral Activity
Angelo Oneto, Ghazl Al Hamwi, Laura Schäkel, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 17, pp. 14986-15011
Closed Access | Times Cited: 3

DrugAssist: a large language model for molecule optimization
Geyan Ye, Xibao Cai, Houtim Lai, et al.
Briefings in Bioinformatics (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 3

Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization
Beatrice Mercorelli, Jenny Desantis, Marta Celegato, et al.
Antiviral Research (2022) Vol. 204, pp. 105350-105350
Open Access | Times Cited: 15

Page 1 - Next Page

Scroll to top